ПРОМЕНЕВА ТЕРАПІЯ ПРИ КІСТКОВИХ МЕТАСТАЗАХ РАКУ МОЛОЧНОЇ ЗАЛОЗИ
Игорь Александрович Гулидов, В. В. Крылов, Е. В. Лукьянова et al. · The Scientific Issues of Ternopil Volodymyr Hnatiuk National Pedagogical University Series pedagogy · 2015
Results of treatment of 579 patients with breast carcinoma with bone metastases by external beam radiation therapy (EBRT) and radionuclide therapy (RNT) (samarium-oksabifor, 153Sm and strontium chloride, 89Sr), the mixed therapy (EBRT and RNT 153Sm – oksabifor) are presented in article. Average time without recurrence of pain with follow-up one year for mixed radiation therapy 9,3 months, EBRT – 7,3 months, RNT 153Sm and 89Sr – 6,8 and 3,8 months, respectively. According to this criterion the mixed method of therapy appeared the most effective. The presented data confirm the developed opinion on high efficiency of methods of palliative radiation therapy at bone metastases, and the technique of the mixed therapy offered by us including single EBRT in the dose 8Gy and RNT 153Sm-oksabifor confirmed the expected effect in the form of further improvement of results against the admissible passing toxic effect.
Cited by 0 works.